Brief: India's Bharat Parenterals Posts March-Qtr Loss
30/05/2018 13:14
May 30 (Reuters) - Bharat Parenterals Ltd BATP.BO :
* MARCH QUARTER NET LOSS 25.6 MILLION RUPEES VERSUS PROFIT
26.7
MILLION RUPEES YEAR AGO
* MARCH QUARTER REVENUE FROM OPERATIONS 417.6 MILLION
RUPEES
VERSUS 336.5 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE74Sgmt
Further company coverage: BATP.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bharat Parenterals
See all newsBrief: Bharat Parenterals Says U.S. FDA Conducts Surprise Inspection At Innoxel Lifesciences Vadodara Facility
India's Bharat Parenteral rebounds on successful completion of EU GMP inspection
Brief: Bharat Parenterals Says Innoxel Lifesciences Completes EU GMP Inspection By Belgium's FAMHP
India's Bharat Parenterals jump after unit clears US FDA inspection
Brief: Bharat Parenterals Secures $27 Mln Order For Pharmaceutical Products